Angiomyolipoma

Medications for Renal Angiomyolipoma

Other titles: Angiomyolipoma

About Renal Angiomyolipoma: Renal angiomyolipomas are one of probably the most frequent benign tumour of the kidney.

This set of medications are somehow related to, or found in the treatment of this condition.

Drug title	Rx / OTC	Pregnancy	CSA	Reviews	Rating
Afinitor	Rx	D	N	1 inspection	9.0
Generic name: everolimus systemic Medicine category: mTOR inhibitors, discerning immunosuppressants For users: dose, interactions, side effects For specialists: AHFS DI Monograph, Prescribing Information

everolimus	Rx	D	N	1 inspection	9.0
Generic name: everolimus systemic Brand name: Afinitor Medicine category: mTOR inhibitors, discerning immunosuppressants For users: dose, interactions, For professionals: A-Z Drug Truth, AHFS DI Monograph

Rx	Prescription Only
OTC	Over the Counter
Rx/OTC	Prescription or Over The Counter
Off Label	This drug might well not be accepted by the FDA for treating the condition.

Pregnancy Category
A	sufficient and well-controlled studies have failed to demonstrate a risk to the fetus in the first trimester of pregnancy (and there is no evidence of risk in later trimesters).
B	Animal reproduction studies have failed to show a risk to the fetus and there are no adequate and well-controlled studies in elderly women.
C	Animal reproduction studies have demonstrated an adverse effect in the fetus and there are no adequate and well-controlled studies in humans, but possible benefits may warrant use in pregnant women despite potential risks.
D	there was positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but possible benefits may warrant use in pregnant women despite potential risks.
X	Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and also the risks involved with use in elderly women obviously outweigh potential rewards.
N	FDA has not classified the drug.

Controlled Substances Act (CSA) Program
N	isn`t subject to the Controlled Substances Act.
1	features a higher possibility of misuse. Has no currently accepted medical use in treatment in the USA. There is a lack of accepted safety for use under medical supervision.
Two	features a higher possibility of misuse. Features a currently accepted medical use in treatment in the USA or a currently accepted medical use with severe restrictions. Abuse may result in severe psychological or physical dependency.
3	includes a potential for abuse less than those in schedules 1 and two. Features a currently accepted medical use in treatment in the USA. Abuse may lead to physical dependence or high psychological dependence.
4	features a low potential for abuse in accordance with those in schedule 3. It has a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 3.
5	features a low potential for abuse in accordance with those in schedule 4. Features a currently accepted medical use in treatment in the USA. Abuse may lead to limited physical dependence or psychological dependence.

Infection
X	Interacts with Medication.

Always ask your physician to ensure the information pertains to your circumstances.